Picture EBD Group BIO-Europe Spring 2021 Digital 650x80
Organisation › Details

CureVac N.V. (Nasdaq: CVAC)

Period Start 2020-08-10 existent
  Predecessor CureVac AG
Products Industry mRNA technology
  Industry 2 mRNA-based drug
Persons Person Haas, Franz-Werner (CureVac 202008– CEO joined 201206 as COO before Sygnis + Lion BIoscience)
  Person 2 Hoerr, Ingmar (CureVac 201806– Chairman of Supervisory Board before 2000–201806 CEO + Co-Founder)
Region Region Netherlands_oo
  Country Netherlands
  City n. a. 
    Address record changed: 2020-08-12
Basic data Employees n. a.
Record changed: 2021-02-20


Picture Kentro Design Corporate and Web Design Berlin 650x65px

More documents for CureVac N.V. (Nasdaq: CVAC)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture Berlin Partner Life Sciences Report 2019/2020 Brandenburg 650x80px

» top